Is a 50% Y/Y EBITDA Decline in the Bag? Hims & Hers Consensus Expectations for Monday's Results

Consensus Estimates + Valuation Context

GLP-1 compounding is big business! Take a look at how bad the drop-off will be for Hims & Hers EBITDA as those stronger margin results roll-off. When we get the 1Q results, pay close attention to Subscribers, Monthly Revenue per Subscriber, and the full year EBITDA growth expectation. If we are still looking at growth this year and with a more stable product and service portfolio underpinning results (hello peptides and lab work), this 30x forward earnings starts to look reasonable.

Here are Consensus expectations for 1Q as well as 2Q and FY guidance: